Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
NVCT | US
0.09
1.18%
Healthcare
Biotechnology
30/06/2024
21/10/2024
7.69
7.78
8.06
7.35
Nuvectis Pharma Inc. a biopharmaceutical company focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. The company develops NXP800 a novel heat shock factor 1 pathway inhibitor for the treatment of various cancers; and NXP900 a small molecule drug candidate that inhibits the Proto-oncogene c-Src and YES1 kinases. It has license agreement with the CRT Pioneer Fund for the NXP800 and any of related derivatives; and the University of Edinburgh for the NXP900 and any of associated derivatives. The company was formerly known as Centry Pharma Inc. and changed its name to Nuvectis Pharma Inc. in July 2021. Nuvectis Pharma Inc. was incorporated in 2020 and is based in Fort Lee New Jersey.
View LessPositive Momentum
Strength based on increasing price with high volume
Low Market Beta (-0.4 to 0.8)
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Rich in Valuation (Price to Book > 8)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
57.2%1 month
51.4%3 months
65.3%6 months
72.5%-
-
11.32
-
-
-7.38
-
-
-
143.44M
143.44M
-
-
-
-
-128.44
11.11
10.43
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
2.10
Range1M
2.16
Range3M
2.21
Rel. volume
1.94
Price X volume
1.54M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Centrexion Therapeutics Corporation | CNTX | Biotechnology | 2.06 | 154.50M | 0.98% | n/a | 0.00% |
| Compugen Ltd | CGEN | Biotechnology | 1.71 | 153.11M | 0.00% | n/a | 5.19% |
| Repare Therapeutics Inc | RPTX | Biotechnology | 3.6 | 152.80M | 4.96% | n/a | 1.07% |
| Vigil Neuroscience Inc. Common Stock | VIGL | Biotechnology | 3.84 | 152.25M | -3.03% | n/a | 15.72% |
| Generation Bio Co | GBIO | Biotechnology | 2.24 | 149.50M | -0.88% | n/a | 81.41% |
| Inovio Pharmaceuticals Inc | INO | Biotechnology | 5.74 | 149.04M | 2.32% | n/a | 13.42% |
| Rani Therapeutics Holdings Inc. Class A Common Stock | RANI | Biotechnology | 2.57 | 148.72M | -4.10% | n/a | 1243.32% |
| Inventiva S.A | IVA | Biotechnology | 2.73 | 144.01M | 3.80% | n/a | -115.26% |
| Verastem Inc | VSTM | Biotechnology | 3.57 | 143.67M | 20.61% | n/a | 104.63% |
| Checkpoint Therapeutics Inc | CKPT | Biotechnology | 3.18 | 143.16M | 5.65% | n/a | 0.00% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 7.55 | 145.88M | -0.79% | n/a | 58.43% |
| Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 32.87 | 94.40M | 1.83% | 5.16 | 19.82% |
| Saga Communications Inc | SGA | Broadcasting - Radio | 14.22 | 89.04M | -1.80% | 14.48 | 7.10% |
| Urban One Inc | UONEK | Broadcasting - Radio | 1.01 | 53.54M | -3.35% | n/a | 268.43% |
| Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 13.44 | 20.47M | 4.19% | n/a | 204.46% |
| ILAG | ILAG | Building Products & Equipment | 1 | 18.06M | -2.91% | n/a | 5.48% |
| Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.5263 | 7.69M | -2.17% | 0.03 | 16.03% |
| Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.4659 | 4.44M | -2.96% | n/a | 19.98% |
| Forza X1 Inc | FRZA | Recreational Vehicles | 0.19 | 2.99M | -13.68% | n/a | 0.97% |
| EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.06 | 2.71M | 0.00% | n/a | 17.32% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -7.38 | - | Cheaper |
| Ent. to Revenue | - | - | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 11.32 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 65.34 | - | Par |
| Debt to Equity | - | -1.23 | - |
| Debt to Assets | - | 0.25 | - |
| Market Cap | 143.44M | - | Emerging |